Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Royalty Thingy

The Royalty Thingy

posted on Apr 05, 2006 08:35AM

With more than a few comments about continuing royalties to be paid by Casio and/or others, one could also look at the other side of the coin.

If PTSC`s BOD believes in their case(s) so strongly that they authorized not one, but two dividends without the guarantee of continuing royalties, what does that say about the BOD`s belief in future revenues?

Yep, they could be wrong. However,IMO, that would be a good thing.

We don`t know the details of these agreements and I doubt we will see the specifics as that would certainly hurt future negotiations if the initial deals are ``easy`` buttons and the later contain the pain.

John

Share
New Message
Please login to post a reply